BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.980
-0.080 (-2.61%)
At close: May 15, 2026, 4:00 PM EDT
3.060
+0.080 (2.68%)
After-hours: May 15, 2026, 5:52 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $12.52 million as of May 15, 2026. Its market cap has increased by 21.37% in one year.
Market Cap
12.52M
Enterprise Value
6.43M
1-Year Change
21.37%
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $12.52M, a decrease of -62.95%. That is a compound annual growth rate of -5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 12.52M | -4.44% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 13.35M |
| Vyome Holdings | 13.27M |
| Cyclerion Therapeutics | 13.19M |
| Cellectar Biosciences | 13.10M |
| Phio Pharmaceuticals | 12.43M |
| GT Biopharma | 12.43M |
| Intensity Therapeutics | 12.27M |
| Jupiter Neurosciences | 12.26M |